Results 31 to 40 of about 3,130,322 (229)

En-block cytoreduction for advanced ovarian cancer

Gynecologic Oncology Reports, 2023
The standard treatment of advanced ovarian, fallopian tube and peritoneal cancer is cytoreductive surgery followed by platinum-based chemotherapy (du Bois et al., 2005). This type of cancer expands through the peritoneum, which is the thin and continuous
Anastasios Pandraklakis, Vasilis Mitsopoulos, Ioannis Biliatis   +2 more
doaj   +1 more source

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [PDF]

, 2006
OBJECTIVE: Residual disease after initial surgery for ovarian cancer is the strongest prognostic factor for survival. However, the extent of surgical resection required to achieve optimal cytoreduction is controversial.
Jones, Monica B., C Robert Stanhope, Timothy O. Wilson, William A. Cliby, Aletti, Giovanni D., Gostout, Bobbie S., Wilson, Timothy O., Stanhope, C. Robert, Podratz, Karl C., Giovanni D. Aletti, Karl C. Podratz, Cliby, William A., Bobbie S. Gostout, Monica B. Jones, Dowdy, Sean C., Sean C. Dowdy   +15 more
core   +1 more source

Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)

Pleura and Peritoneum, 2023
There are limited treatment options and no consensus on the management of advanced rare ovarian malignancies. Rare ovarian malignancies can present with peritoneal metastases (PM), featuring a similar presentation to more common ovarian subtypes ...
Falla-Zuniga Luis Felipe, Sardi Armando, King Mary Caitlin, Lopez-Ramirez Felipe, Barakat Philipp, Nieroda Carol, Diaz-Montes Teresa, Gushchin Vadim   +7 more
doaj   +1 more source

Evaluation of the relationship between lactacidemia and postoperative complications after surgery for peritoneal carcinomatosis [PDF]

Korean Journal of Anesthesiology, 2021
Background Cytoreductive surgery was developed as a treatment for peritoneal carcinomatosis. However, this surgery is associated with important complications.
Marta Soriano Hervás, Rosa Játiva-Porcar, Daniel Robles-Hernández, Anna Serra Rubert, Blanca Segarra, Cristina Oliva, Javier Escrig, José Antonio Llueca   +7 more
doaj   +1 more source

EP812 Impact of incorporation of extensive surgical procedures on surgical outcomes in advanced ovarian cancer

International Journal of Gynecological Cancer, 2019
Introduction/Background Epithelial ovarian cancer (EOC) is the most lethal gynaecologic malignancy. Most patients present with advanced stage disease. The most important prognostic factor is cytoreduction to no macroscopic residual tumour, which could ...
L. Cárdenas Puiggrós, A. T. Pons, C. Fina Planas, MP Barretina Ginesta, E. S. Hernández, E. Á. Castaño   +5 more
semanticscholar   +1 more source

Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma – A systematic review

Journal of Bone Oncology, 2023
Background: Bone metastases (BM) are uncommon in endometrial carcinoma (EC), without information on the optimal oncologic management of patients with BM in EC. Here, we systematically review clinical characteristics, treatment approaches and prognosis in
Martin Heidinger, Elisa Simonnet, Li Mei Koh, Brigitte Frey Tirri, Marcus Vetter   +4 more
doaj   +1 more source

Perioperative management of cytoreductive surgery and hyperthermic intraoperative thoraco-abdominal chemotherapy (HITAC) for pseudomyxoma peritonei

Indian Journal of Anaesthesia, 2019
Peritoneal carcinomatosis is intraperitoneal spread of gastrointestinal and gynaecological cancers. Cytoreductive surgeries and hyperthermic intraperitoneal chemotherapy offers survival benefits in these cases.
Sohan Lal Solanki, Jhanvi S Bajaj, Febin Rahman, Avanish P Saklani   +3 more
doaj   +1 more source

Intrathoracic gastric volvulus as a severe, delayed surgical complication after left subphrenic peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancer. [PDF]

, 2013
Patients with extensive peritoneal spread from advanced ovarian cancer often undergo several upper abdominal surgical procedures including subphrenic peritonectomy to obtain optimal cytoreduction.
Roberto Caronna, Piero Chirletti, CARONNA, Roberto, Bianca Maria Sollazzo, CHIRLETTI, Piero, FRAMARINO DEI MALATESTA, Marialuisa, SAMMARTINO, Paolo, MENICONI, ROBERTO LUCA, Paolo Sammartino, Maria Framarino, Bianca Sollazzo, Roberto Meniconi   +11 more
core   +1 more source

Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

Indian Journal of Anaesthesia, 2019
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for primary peritoneal malignancies or peritoneal spread of malignant neoplasm is being done at many centres worldwide.
Sohan Lal Solanki, Sudipta Mukherjee, Vandana Agarwal, Raghu S Thota, Kalpana Balakrishnan, Shagun Bhatia Shah, Neha Desai, Rakesh Garg, Reshma P Ambulkar, Nitin Madhukar Bhorkar, Viplab Patro, Snita Sinukumar, Meenakshi V Venketeswaran, Malini P Joshi, Rajesh Holalu Chikkalingegowda, Vijaya Gottumukkala, Pascal Owusu-Agyemang, Avanish P Saklani, Sanket Sharad Mehta, Ramakrishnan Ayloor Seshadri, John C Bell, Sushma Bhatnagar, Jigeeshu V Divatia   +22 more
doaj   +1 more source

EP1021 Laparoscopic primary cytoreduction with multi visceral resection in advanced ovarian cancer: the first experience of 5 procedures

International Journal of Gynecological Cancer, 2019
Introduction/Background Standard approach for the initial treatment of advanced ovarian cancer (AOC) is surgical removal of all visible implants of the disease through a large midline laparotomy.
S. Baydo, A. Vinnytska, D. Golub
semanticscholar   +1 more source